Physician profile
Leah M Adkins
NPI 1902931769
$10,590.21
in general payments reported to CMS, 2019-2025
41 companies · $730 in 2025
The $730 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.28 · 2020: $105 · 2021: $752 · 2022: $1,283 · 2023: $6,977 · 2024: $652 · 2025: $730.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $5,475 · Food and Beverage: $2,702 · Travel and Lodging: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $5,475.00 |
| Food and Beverage | $2,701.56 |
| Travel and Lodging | $182.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Women'S Health, INC. | $6,203.92 | 2023 | Myrisk, Genesight |
| Abbvie INC. | $1,046.07 | 2019-2025 | Ubrelvy, Qulipta, Liletta |
| Aspira Women'S Health INC | $718.42 | 2021-2024 | Ova1 |
| Mayne Pharma Commercial LLC | $329.93 | 2021-2025 | |
| Astellas Pharma US INC | $239.18 | 2022-2025 | Veozah |
| Therapeuticsmd, INC. | $200.49 | 2019-2022 | |
| Exeltis, USA INC. | $172.11 | 2021-2025 | Slynd |
| Agile Therapeutics, INC. | $143.66 | 2021-2024 | Twirla |
| Gynesonics, INC. | $128.03 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Hologic Sales and Service, LLC | $123.73 | 2022-2023 | Myosure Tissue Removal Device, Novasure, Coolseal Generator |
| Daiichi Sankyo INC. | $88.77 | 2021-2024 | Injectafer |
| Pfizer INC. | $88.39 | 2023-2024 | |
| Myovant Sciences INC. | $86.25 | 2021-2022 | |
| Biogen, INC. | $82.36 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $76.90 | 2023-2025 | Myfembree, Gemtesa |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $69.77 | 2021-2022 | |
| Organon LLC | $66.75 | 2021-2025 | Nexplanon, Jada System |
| Millicent US INC | $61.51 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Shield Therapeutics INC | $59.58 | 2023-2025 | Accrufer |
| Biohaven Pharmaceuticals, INC. | $58.25 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $52.41 | 2022-2025 | |
| Evofem Biosciences, INC. | $42.48 | 2021 | |
| Baxter Healthcare | $38.22 | 2024-2025 | Tisseel, Perclot |
| Amgen INC. | $38.18 | 2024-2025 | Evenity, Prolia, Prolia |
| Biohaven Pharmaceutical Holding Company Ltd. | $36.08 | 2022 | |
| Ibsa Pharma INC. | $32.77 | 2023 | Tirosint, Licart |
| Davol INC. | $30.15 | 2022 | |
| Ethicon US, LLC | $28.06 | 2023 | Dermabond Prineo, Stratafix |
| Optumhealth Care Solutions, LLC | $27.61 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Minerva Surgical, INC | $26.72 | 2021-2024 | |
| Avion Pharmaceuticals | $24.99 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $24.68 | 2024 | Iovera, Zilretta, Exparel |
| Allergan, INC. | $24.09 | 2019 | |
| Exact Sciences Corporation | $21.46 | 2024 | Cologuard Collection Kit |
| Coopersurgical, INC. | $21.23 | 2024 | Paragard T 380a |
| Sanofi Pasteur INC. | $19.34 | 2024 | |
| Merck Sharp & Dohme LLC | $16.41 | 2021 | |
| Caldera Medical, INC | $15.42 | 2023 | Desara |
| Scynexis, INC. | $14.08 | 2022 | |
| Medtronic, INC. | $11.76 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leah Adkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.